Showing posts with label Fda Advisers. Show all posts
Showing posts with label Fda Advisers. Show all posts

Sunday, 13 May 2012

Food And Drug Administration-Cardiovascular Side Effects-Healthday News

FDA Advisers Back Pill to Help Prevent HIV Infection

THURSDAY, May 10 (Healthday News) -- U.S. Food and Drug Administration advisers on Thursday endorsed the use of the drug Truvada as a means to help prevent HIV infection in healthy people at high risk of contracting the AIDS-causing virus. read more..


FDA Panel Gives Blessing to New Weight-Loss Drug

THURSDAY, May 10 (Healthday News) -- An advisory panel to the U.S. Food and Drug Administration on Thursday recommended approval of the weight-loss medication lorcaserin, even though concerns remain about cardiovascular side effects. read more..

Thursday, 1 March 2012

Oral Contraceptives-Healthday News-Fda Advisers-Labels

FDA Advisers: Newer Forms of the 'Pill' Need Revised Warning Labels

THURSDAY, Dec. 8 (HealthDay News) -- U.S. health advisers recommended Thursday that several newer forms of oral contraceptives carry revised labels warning about an increased risk of potentially fatal blood clots. read more..

Saturday, 25 February 2012

Food And Drug Administration-Healthday News-Fda Advisers-Weight Loss

FDA Advisers Back Weight-Loss Drug Qnexa

WEDNESDAY, Feb. 22 (HealthDay News) -- A U.S. Food and Drug Administration advisory panel gave its blessing Wednesday to a highly anticipated weight loss pill that had been rejected by health advisers once before. read more..